Episodes 16-30 of 1191
FDA Approves Remdesivir, the First COVID-19 Treatment
The Drug ReportFDA Approves Remdesivir, the First COVID-19 Treatment
Reopening Practices in Light of COVID-19
Perspectives with the AMAReopening Practices in Light of COVID-19
Investigating the Circulation of Counterfeit COVID-19 Medications
COVID-19: On The FrontlinesInvestigating the Circulation of Counterfeit COVID-19 Medications
Advocacy Efforts During the COVID-19 Pandemic
Perspectives with the AMAAdvocacy Efforts During the COVID-19 Pandemic
Perspectives on Responding Administratively to a Pandemic: Notes from a Children’s Hospital
COVID-19: On The FrontlinesPerspectives on Responding Administratively to a Pandemic: Notes from a Children’s Hospital
Artificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
Clinician's RoundtableArtificial Intelligence’s Role in Combating the Antibiotic Resistance Crisis
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
The Drug ReportThe DEA’s Adjustment to Schedule II Rules Amid COVID-19
FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
The Drug ReportFDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19
Off-Label Medicines in Fighting COVID-19 & Through the Years
COVID-19: On The FrontlinesOff-Label Medicines in Fighting COVID-19 & Through the Years
HHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
The Drug ReportHHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
Drug Shortages During the COVID-19 Pandemic
The Drug ReportDrug Shortages During the COVID-19 Pandemic
Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
The Drug ReportNovel Therapeutic & Prevention Approaches to the Novel Coronavirus
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
The Drug ReportUncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
